SEQUENCE LISTING <110> CENTRO DE INMUNOLOGIA MOLECULAR <120> ANTICUERPOS RECOMBINANTES CON ESPECIFICIDAD DUAL POR GANGLIOSIDOS <130> 422014CO00 <140> P3582 <141> 2014-02-21 <160> 39 <170> PatentIn version 3.5 <210> 1 <211> 125 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 1 Gln Val Gln Leu Gln Gln Ser Gly Asn Glu Leu Ala Lys Pro Gly Ala 1 5 10 15 Ser Met Lys Met Ser Cys Arg Ala Ser Gly Tyr Arg Phe Arg Ser Tyr 20 25 30 Gln Ile His Trp Leu Lys Gln Arg Pro Asp Gln Gly Leu Glu Trp Ile 35 40 45 Gly Tyr Ile Asp Pro Ala Thr Ala Tyr Thr Glu Ser Asn Gln Lys Phe 50 55 60 Lys Asp Lys Ala Ile Leu Thr Ala Asp Arg Ser Ser Asn Thr Ala Phe 65 70 75 80 Met Tyr Leu Asn Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 85 90 95 Ala Arg Glu Ser Pro Arg Leu Arg Arg Gly Ile Tyr Tyr Tyr Ala Met 100 105 110 Asp Tyr Trp Gly Gln Gly Thr Ser Val Thr Val Ser Ser 115 120 125 <210> 2 <211> 109 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 2 Asp Leu Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Val Thr Pro Gly 1 5 10 15 Asp Ser Val Ser Phe Ser Cys Arg Ala Ser Gln Ser Ile Ser Asn Asn 20 25 30 Leu His Trp Tyr Gln Gln Arg Thr His Glu Ser Pro Arg Leu Leu Ile 35 40 45 Lys Tyr Ala Ser Gln Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly 50 55 60 Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Ile Ser Val Glu Thr 65 70 75 80 Glu Asp Phe Gly Met Tyr Phe Cys Gln Gln Ser Asn Arg Trp Pro Leu 85 90 95 Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys Arg Ala 100 105 <210> 3 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 3 Gly Tyr Arg Phe Arg Ser Tyr Gln Ile His 1 5 10 <210> 4 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 4 Gly Tyr Ser Phe Thr Arg Tyr Gln Ile His 1 5 10 <210> 5 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 5 Gly Tyr Arg Phe Thr Ser Asn Gln Ile His 1 5 10 <210> 6 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 6 Gly Tyr Ser Phe Asn Arg Tyr Gln Ile His 1 5 10 <210> 7 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 7 Gly Tyr Ser Phe Arg Arg Tyr Gln Ile His 1 5 10 <210> 8 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 8 Gly Tyr Ser Ile Thr Arg Tyr Gln Ile His 1 5 10 <210> 9 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 9 Gly Tyr Ser Phe Thr Arg Tyr Gln Ile His 1 5 10 <210> 10 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 10 Gly Tyr Ser Phe Lys Ser Tyr Gln Ile His 1 5 10 <210> 11 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 11 Gly Tyr Ser Phe Thr Ser Tyr Gln Ile His 1 5 10 <210> 12 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 12 Gly Tyr Arg Phe Thr Arg Tyr Trp Ile His 1 5 10 <210> 13 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 13 Gly Tyr Thr Phe Thr Arg Tyr Gln Ile His 1 5 10 <210> 14 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 14 Gly Tyr Pro Phe Thr Arg Tyr Gln Ile His 1 5 10 <210> 15 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 15 Gly Tyr Ser Phe Ser Arg Tyr Gln Ile Val 1 5 10 <210> 16 <211> 10 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 16 Gly Tyr His Phe Thr Arg Tyr Gln Ile His 1 5 10 <210> 17 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 17 Tyr Ile Asp Pro Ala Thr Ala Tyr Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 18 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 18 Tyr Ile Asn Pro Ala Thr Ala Ser Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 19 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 19 Phe Ile Asp Pro Ala Thr Ala Tyr Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 20 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 20 Asp Ile Asp Pro Gly Arg Ala Tyr Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 21 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 21 Tyr Ile Asp Pro Ala Thr Ala Asn Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 22 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 22 Phe Ile Asn Pro Ala Thr Ala Tyr Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 23 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 23 Phe Ile Asp Pro Ala Ser Ala Tyr Thr Val Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 24 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 24 Tyr Ile Asp Pro Ala Thr Ala Lys Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 25 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 25 Tyr Ile Asn Pro Gly Ser Ala Tyr Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 26 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 26 Tyr Leu Asp Pro Ala Asn Ala Tyr Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 27 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 27 Tyr Val Asp Pro Ala Asn Ala Tyr Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 28 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 28 Tyr Ile Asn Pro Ala Thr Ala Tyr Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 29 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 29 Tyr Ile Asp Pro Ala Thr Ala Trp Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 30 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 30 Tyr Ile Asp Pro Gly Thr Ala Tyr Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 31 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 31 Tyr Ile Asp Pro Arg Thr Ala Tyr Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 32 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 32 Tyr Val Asp Pro Ala Thr Ala His Thr Glu Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 33 <211> 17 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 33 Tyr Ile Asn Pro Ala Thr Ala Tyr Thr Asp Ser Asn Gln Lys Phe Lys 1 5 10 15 Asp <210> 34 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 34 Glu Ser Pro Arg Leu Arg Arg Gly Ile Tyr Tyr Tyr Ala Met Asp Tyr 1 5 10 15 <210> 35 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 35 Glu Ser Pro Arg Phe Arg Arg Gly Arg Tyr Tyr Tyr Ala Met Asp Tyr 1 5 10 15 <210> 36 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 36 Glu Ser Pro Arg Met Arg Arg Gly Ile Tyr Tyr Tyr Ala Met Asp Tyr 1 5 10 15 <210> 37 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 37 Glu Ser Pro Arg Val Arg Arg Gly Ile Tyr Tyr Tyr Ala Met Asp Tyr 1 5 10 15 <210> 38 <211> 16 <212> PRT <213> Artificial Sequence <220> <223> Recombinant <400> 38 Glu Ser Pro Arg Leu Arg Arg Gly Leu Tyr Tyr Tyr Ala Met Asp Tyr 1 5 10 15 <210> 39 <211> 107 <212> PRT <213> Artificial Sequence <220> <223> recombinant <400> 39 Asp Ile Gln Met Thr Gln Thr Pro Ser Ser Leu Ser Ala Ser Leu Gly 1 5 10 15 Asp Arg Val Thr Ile Ser Cys Arg Ala Ser Gln Asp Ile Ser Asn Tyr 20 25 30 Leu Asn Trp Tyr Gln Gln Lys Pro Asp Gly Thr Val Lys Leu Leu Ile 35 40 45 Val Tyr Thr Ser Arg Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 50 55 60 Ser Gly Ser Gly Thr Asp Tyr Ser Leu Thr Ile Ser Asn Leu Glu Gln 65 70 75 80 Glu Asp Ile Ala Thr Tyr Phe Cys Gln Gln Gly Asn Thr Leu Pro Pro 85 90 95 Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys 100 105